Leavitt Partners Blog

Implications of the 2018 Midterm Elections
November 16, 2018

Health care was a central issue in this year’s midterm elections. In the days after the election, many have speculated on what the results mean for U.S. health care policy. Since the Republicans maintained control of the Senate, while the Democrats took control of the House, some see the next two years as a time […]

Read More >
Paying for Poor Choices
October 23, 2018

Early this year former Treasury Secretary Larry Summers made a case for taxing sugary drinks and cigarettes to deter individuals from consuming products that lead to obesity and chronic disease. Taxing such products could gain importance as policy makers consider comprehensive coverage policies such as “Medicare for all.” The reason is based both on principle […]

Read More >
Medicaid Closed Drug Formularies: A Closed Door or a Path Forward?
October 2, 2018

As we noted in July, CMS declined Massachusetts’ Medicaid 1115 demonstration request to establish a closed formulary.  The proposed program would have given Massachusetts the ability to exclude certain FDA-approved drugs from coverage and thereby given the state additional leverage in negotiating rebates.  The state and drug manufacturers would have otherwise continued to be subject […]

Read More >
A Uniquely American Health System
August 16, 2018

As the United States continues to move toward a value-based health care system, significant challenges slow down our progress. Political pressure exists from all sides, incentives have yet to be appropriately aligned, and the pressing need to change stakeholder behavior remains a time-sensitive imperative. Solving these challenges requires going beyond admiring the challenges to implementing […]

Read More >
Promoting Diabetes Prevention for Federal Employees
June 4, 2018

For the second year in a row, Leavitt Partners presented on diabetes prevention at the Office of Personnel Management (OPM) annual carrier conference. The presentation was made on behalf of the National Association of Chronic Disease Directors (NACDD) and alongside the Centers for Disease Control and Prevention (CDC) Division of Diabetes Translation (DDT). OPM’s Federal […]

Read More >
Pace of 2018 Open Enrollment is Above Previous Years, But Is It Enough to Close the Gap?
December 11, 2017

The latest information from the Centers for Medicare & Medicaid Services (CMS)[1] on the number of plan selections for the current Open Enrollment Period (EOP) has been a positive sign for stakeholders that are hoping for a large and stable enrollment cycle. While the number of plan selections has been higher than in the previous […]

Read More >
The National DPP Coverage Toolkit: Timely Tools for Payers Addressing Prediabetes
August 30, 2017

More than 86 million American adults have prediabetes. That number alone is astounding, but perhaps what is even more concerning is that 9 out of 10 people with prediabetes don’t know they have it. Considering that, in the absence of any health intervention, 15‒30 percent of people with prediabetes will develop type 2 diabetes within five years, effective preventive measures are needed to mitigate a serious public health crisis. The Centers for Disease Control and Prevention (CDC) is proactively responding to this potential problem by developing and promoting the National Diabetes Prevention Program (National DPP) lifestyle change program.

Read More >
The Opioid Epidemic and State Responses
August 17, 2017

According to the National Institute on Drug Abuse and the CDC, in 2015 over 33,000 people died from opioid overdose in the United States, and in 2013 prescription opioid abuse cost the U.S. economy approximately $78.5 billion in costs related to health care, crime, and loss of productivity. Opioid abuse and the related overdose deaths […]

Read More >